- Home
- REFI vs RNAC Comparison
REFI vs RNAC Comparison
Compare REFI & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REFI | RNAC |
|---|---|---|
| Founded | 2021 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 257.7M | 218.4M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | REFI | RNAC |
|---|---|---|
| Price | $9.42 | $7.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $15.13 | ★ $33.67 |
| AVG Volume (30 Days) | ★ 205.8K | 131.8K |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | ★ 19.50% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.57 | N/A |
| Revenue | ★ $48,857,628.00 | $2,797,000.00 |
| Revenue This Year | $0.76 | N/A |
| Revenue Next Year | $7.89 | N/A |
| P/E Ratio | $16.91 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.57 | $5.60 |
| 52 Week High | $13.49 | $11.00 |
Technical Indicators
Market Signals| Indicator | REFI | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 23.82 | 35.10 |
| Support Level | N/A | $5.88 |
| Resistance Level | $10.97 | $7.50 |
| Average True Range (ATR) | 0.23 | 0.36 |
| MACD | -0.13 | -0.02 |
| Stochastic Oscillator | 0.66 | 29.40 |
Price Performance
Historical ComparisonAbout REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. The Company operates as one operating segment, and its primary investment objective is to provide attractive, risk-adjusted returns for stockholders over time, mainly through consistent current income (dividends and distributions) and secondarily, through capital appreciation. The company operates mainly within the USA itself.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.